Side Effects of Azelastine Ophthalmic Solution

Some of the most common side effects of azelastine ophthalmic solution include headaches, a bitter taste, and temporary eye burning or stinging. Other side effects that have been reported by people using these eye drops include fatigue, eye pain, and blurred vision. While most side effects of this medication are minor, some require immediate medical attention, including asthma or signs of an allergic reaction.

An Introduction to Azelastine Ophthalmic Solution Side Effects

As with any medicine, azelastine ophthalmic solution (Optivar®) can cause side effects. However, not everyone who takes the medication will have problems. In fact, some people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or are easily treated by you or your healthcare provider.
 
(This article covers many, but not all, of the possible side effects with this drug. Your healthcare provider can discuss a more complete list of azelastine ophthalmic solution side effects with you.)
 

Serious Azelastine Ophthalmic Solution Side Effects

Some side effects with azelastine ophthalmic solution, while occurring infrequently, are potentially serious and should be reported immediately to your healthcare provider. These include, but are not limited to:
 
  • Asthma
  • Signs of an allergic reaction to the medication, such as:

 

    • An unexplained rash or hives
    • Itching (more than the usual itching related to eye allergies)
    • Unexplained swelling, especially of the mouth, lips, or throat
    • Wheezing or difficulty breathing.

 

Of course, any eye drop can cause problems (such as an eye infection) if it is contaminated, so be sure to avoid touching the tip of the dropper to any surface, including the surface of the eye. Report any signs of an eye infection (such as severe pain, swelling, or redness) to your healthcare provider right away.
 
(Side Effects of Azelastine Ophthalmic Solution Continued: Page 2)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;
Other Articles in This eMedTV Presentation